17/08/2025
People with type 2 diabetes face a higher risk of developing dementia. But a new study suggests that a specific class of diabetes medications, called GLP-1s, may significantly lower that risk compared to another common medication, metformin.
“Obesity, insulin resistance, and type 2 diabetes are all known to increase the risk of dementia, largely due to their role in driving inflammation, vascular damage, and other long-term stressors on the brain. By targeting these underlying issues, GLP-1s, which are already widely used to treat obesity and diabetes, may offer indirect protection against cognitive diseases,” says Dr. Michael Snyder, bariatric surgeon with HCA HealthONE. Learn more about the study: https://bit.ly/4mFgyv0
Interested in learning more about how we can help you manage your health? Learn more about our weight loss programs at https://bit.ly/4fGIaxl
People taking GLP-1 agonists for diabetes have a significantly lower risk of developing dementia compared to those using metformin, a new study has found.